Yousif Capital Management LLC Increases Stake in Axon Enterprise, Inc $AXON

Yousif Capital Management LLC lifted its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 1.1% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 10,066 shares of the biotechnology company’s stock after buying an additional 105 shares during the period. Yousif Capital Management LLC’s holdings in Axon Enterprise were worth $8,334,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of AXON. Brighton Jones LLC purchased a new position in shares of Axon Enterprise during the fourth quarter valued at about $480,000. GAMMA Investing LLC increased its position in shares of Axon Enterprise by 11.8% during the first quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock valued at $765,000 after buying an additional 154 shares during the period. CX Institutional purchased a new position in shares of Axon Enterprise during the first quarter valued at about $115,000. Fifth Third Bancorp increased its position in shares of Axon Enterprise by 91.2% during the first quarter. Fifth Third Bancorp now owns 2,923 shares of the biotechnology company’s stock valued at $1,537,000 after buying an additional 1,394 shares during the period. Finally, Ritholtz Wealth Management increased its position in shares of Axon Enterprise by 14.0% during the first quarter. Ritholtz Wealth Management now owns 702 shares of the biotechnology company’s stock valued at $369,000 after buying an additional 86 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 1.0%

Shares of NASDAQ AXON opened at $710.00 on Tuesday. The firm’s 50 day moving average price is $754.87 and its 200-day moving average price is $716.06. The company has a market cap of $55.74 billion, a PE ratio of 175.31, a P/E/G ratio of 27.30 and a beta of 1.41. Axon Enterprise, Inc has a 52-week low of $422.38 and a 52-week high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Transactions at Axon Enterprise

In other news, insider Jeffrey C. Kunins sold 7,891 shares of the company’s stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total value of $5,919,039.10. Following the transaction, the insider owned 144,538 shares in the company, valued at approximately $108,417,953.80. This represents a 5.18% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, President Joshua Isner sold 15,919 shares of the company’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the completion of the transaction, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This represents a 6.26% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock valued at $45,115,616. 5.70% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

AXON has been the topic of several research analyst reports. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 2nd. UBS Group reissued a “neutral” rating and set a $840.00 price objective (up previously from $820.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a research note on Thursday, July 17th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective on the stock in a research note on Tuesday, August 5th. Finally, Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the stock an “overweight” rating in a research note on Friday, July 11th. Fourteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.